Currently out of the existing stock ratings of Eric Criscuolo, 18 are a HOLD (47.37%), 1 are a SELL (2.63%), 19 are a BUY (50%).

Eric Criscuolo

Work Performance Price Targets & Ratings Chart

Analyst Eric Criscuolo works with a stock forecast success ratio of 78.13% fulfilled within 144.63 days on average. Previously, Eric Criscuolo worked at MIZUHO.

Eric Criscuolo’s has documented 62 price targets and ratings displayed on 8 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on CLVS, Clovis Oncology at 24-Aug-2016.

Wall Street Analyst Eric Criscuolo

Analyst best performing recommendations are on XON (PRECIGEN).
The best stock recommendation documented was for EXAS (EXACT SCIENCES) at 5/4/2016. The price target of $12 was fulfilled within 57 days with a profit of $6.19 (106.54%) receiving and performance score of 18.69.

Average potential price target upside

EXAS EXACT Sciences ILMN Illumina MYGN Myriad Genetics TMO Thermo Fisher Scientific CLVS Clovis Oncology FLDM Fluidigm PKI PerkinElmer XON Precigen

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

90

$26.76 (42.31%)

120

2 months 3 days ago

2/7 (28.57%)

$30.51 (51.29%)

39

Hold

91

$27.76 (43.90%)

3 months 23 days ago

9/10 (90%)

$17.23 (23.36%)

154

Buy

160

4 months 12 days ago

15/17 (88.24%)

$35.95 (28.98%)

158

Buy

100

$36.76 (58.13%)

85

5 months 22 days ago

1/3 (33.33%)

$32.98 (49.21%)

18

Buy

80

$16.76 (26.50%)

90

6 months 9 days ago

4/7 (57.14%)

$13.07 (19.53%)

31

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Eric Criscuolo?

On 2012

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?